{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T19:26:55Z","timestamp":1757618815500,"version":"3.44.0"},"reference-count":51,"publisher":"BMJ","issue":"e1","license":[{"start":{"date-parts":[[2021,8,16]],"date-time":"2021-08-16T00:00:00Z","timestamp":1629072000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/bmj.com\/coronavirus\/usage"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Eur J Hosp Pharm"],"accepted":{"date-parts":[[2021,7,5]]},"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1136\/ejhpharm-2021-002776","type":"journal-article","created":{"date-parts":[[2021,8,16]],"date-time":"2021-08-16T14:30:04Z","timestamp":1629124204000},"page":"e2-e5","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Risk factors for nosocomial bloodstream infections in COVID-19 affected patients: protocol for a case\u2013control study"],"prefix":"10.1136","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5997-7359","authenticated-orcid":false,"given":"Carla","family":"Codina-Jim\u00e9nez","sequence":"first","affiliation":[{"name":"Pharmacy Department, Hospital Universitari Germans Trias i Pujol, Badalona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7709-6504","authenticated-orcid":false,"given":"Sergio","family":"Marin","sequence":"additional","affiliation":[{"name":"Pharmacy Department, Hospital Universitari Germans Trias i Pujol, Badalona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5922-7811","authenticated-orcid":false,"given":"Marlene","family":"\u00c1lvarez","sequence":"additional","affiliation":[{"name":"Pharmacy Department, Hospital Universitari Germans Trias i Pujol, Badalona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8360-3787","authenticated-orcid":false,"given":"Maria Dolores","family":"Quesada","sequence":"additional","affiliation":[{"name":"Microbiology Department, Clinical Laboratory North Metropolitan Area, Autonomous University of Barcelona, Hospital Universitari Germans Trias i Pujol, Badalona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1386-2366","authenticated-orcid":false,"given":"Beatriz","family":"Rodr\u00edguez-Ponga","sequence":"additional","affiliation":[{"name":"Microbiology Department, Clinical Laboratory North Metropolitan Area, Autonomous University of Barcelona, Hospital Universitari Germans Trias i Pujol, Badalona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6536-8672","authenticated-orcid":false,"given":"Ester","family":"Valls","sequence":"additional","affiliation":[{"name":"Pharmacy Department, Hospital Universitari Germans Trias i Pujol, Badalona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2974-2086","authenticated-orcid":false,"given":"Carles","family":"Qui\u00f1ones","sequence":"additional","affiliation":[{"name":"Pharmacy Department, Hospital Universitari Germans Trias i Pujol, Badalona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2021,8,16]]},"reference":[{"key":"2025090700315083000_29.e1.e2.1","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.25678"},{"key":"2025090700315083000_29.e1.e2.2","unstructured":"World Health Organization (WHO) . Novel Coronavirus - Situation Report 22, 2020. Available: https:\/\/www.who.int\/indonesia\/news\/novel-coronavirus\/qa-for-public [Accessed Jan 2020]."},{"key":"2025090700315083000_29.e1.e2.3","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1177\/1757177417720998","article-title":"Prevalence and risk factors for bloodstream infection present on hospital admission","volume":"19","author":"Aliyu","year":"2018","journal-title":"J Infect Prev"},{"key":"2025090700315083000_29.e1.e2.4","doi-asserted-by":"publisher","DOI":"10.1086\/500318"},{"key":"2025090700315083000_29.e1.e2.5","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(10)70258-9"},{"key":"2025090700315083000_29.e1.e2.6","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofaa461","article-title":"Epidemiology and risk factors associated with mortality in consecutive patients with bacterial bloodstream infection: impact of MDR and XDR bacteria","volume":"7","author":"Santoro","year":"2020","journal-title":"Open Forum Infect Dis"},{"key":"2025090700315083000_29.e1.e2.7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2018.03.005"},{"key":"2025090700315083000_29.e1.e2.8","doi-asserted-by":"publisher","DOI":"10.1111\/1469-0691.12195"},{"key":"2025090700315083000_29.e1.e2.9","doi-asserted-by":"publisher","DOI":"10.1111\/jgs.12634"},{"key":"2025090700315083000_29.e1.e2.10","doi-asserted-by":"publisher","DOI":"10.1186\/cc10114"},{"key":"2025090700315083000_29.e1.e2.11","doi-asserted-by":"publisher","DOI":"10.1378\/chest.10-1715"},{"key":"2025090700315083000_29.e1.e2.12","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-012-2695-9"},{"key":"2025090700315083000_29.e1.e2.13","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0b013e31817b879c"},{"key":"2025090700315083000_29.e1.e2.14","doi-asserted-by":"publisher","DOI":"10.1086\/340616"},{"key":"2025090700315083000_29.e1.e2.15","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1914433"},{"key":"2025090700315083000_29.e1.e2.16","doi-asserted-by":"crossref","first-page":"e31","DOI":"10.1097\/CCM.0000000000004748","article-title":"Unexpectedly high frequency of enterococcal bloodstream infections in coronavirus disease 2019 patients admitted to an Italian ICU: an observational study","volume":"49","author":"Bonazzetti","year":"2021","journal-title":"Crit Care Med"},{"key":"2025090700315083000_29.e1.e2.17","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.jgar.2020.10.004","article-title":"Incidence of bacterial and fungal bloodstream infections in COVID-19 patients in intensive care: an alarming \"collateral effect\"","volume":"23","author":"Cataldo","year":"2020","journal-title":"J Glob Antimicrob Resist"},{"key":"2025090700315083000_29.e1.e2.18","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1093\/bmb\/ldz033","article-title":"Gram-negative bloodstream infections and sepsis: risk factors, screening tools and surveillance","volume":"132","author":"Mitchell","year":"2019","journal-title":"Br Med Bull"},{"key":"2025090700315083000_29.e1.e2.19","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s15010-018-1230-5","article-title":"Risk factors of bloodstream infections in recipients after liver transplantation: a meta-analysis","volume":"47","author":"He","year":"2019","journal-title":"Infection"},{"key":"2025090700315083000_29.e1.e2.20","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1007\/s13312-016-0932-y","article-title":"Risk factors for central line associated bloodstream infections","volume":"53","author":"Tomar","year":"2016","journal-title":"Indian Pediatr"},{"key":"2025090700315083000_29.e1.e2.21","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ijid.2018.03.022","article-title":"Bloodstream infections in cancer patients. Risk factors associated with mortality","volume":"71","author":"Islas-Mu\u00f1oz","year":"2018","journal-title":"Int J Infect Dis"},{"key":"2025090700315083000_29.e1.e2.22","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jiph.2018.08.011","article-title":"Epidemiological study of secondary bloodstream infections: the forgotten issue","volume":"12","author":"Sante","year":"2019","journal-title":"J Infect Public Health"},{"key":"2025090700315083000_29.e1.e2.23","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.44.1157"},{"key":"2025090700315083000_29.e1.e2.24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7883\/yoken.JJID.2003.1","article-title":"A two-year analysis of risk factors and outcome in patients with bloodstream infection","volume":"56","author":"Endimiani","year":"2003","journal-title":"Jpn J Infect Dis"},{"key":"2025090700315083000_29.e1.e2.25","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.jiph.2014.01.001","article-title":"Prevalence and risk factors for antibiotic-resistant community-associated bloodstream infections","volume":"7","author":"Wolfe","year":"2014","journal-title":"J Infect Public Health"},{"key":"2025090700315083000_29.e1.e2.26","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.cmi.2020.10.017","article-title":"Clinical course and outcomes of critically ill patients with COVID-19 infection: a systematic review","volume":"27","author":"Serafim","year":"2021","journal-title":"Clin Microbiol Infect"},{"key":"2025090700315083000_29.e1.e2.27","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1001\/jama.2020.6775","article-title":"Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the new York City area","volume":"323","author":"Richardson","year":"2020","journal-title":"JAMA"},{"key":"2025090700315083000_29.e1.e2.28","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1056\/NEJMc2010419","article-title":"Clinical characteristics of Covid-19 in New York City","volume":"382","author":"Goyal","year":"2020","journal-title":"N Engl J Med"},{"key":"2025090700315083000_29.e1.e2.29","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30566-3"},{"key":"2025090700315083000_29.e1.e2.30","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2020.10.036"},{"key":"2025090700315083000_29.e1.e2.31","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2020.16747","article-title":"Corticosteroids in COVID-19 ARDS","volume":"324","author":"Prescott","year":"2020","journal-title":"JAMA"},{"key":"2025090700315083000_29.e1.e2.32","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1093\/ofid\/ofaa518","article-title":"Staphylococcus aureus bacteremia in patients infected with COVID-19: a case series","volume":"7","author":"Cusumano","year":"2020","journal-title":"Open Forum Infect Dis"},{"key":"2025090700315083000_29.e1.e2.33","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1080\/22221751.2020.1812437","article-title":"Risks and features of secondary infections in severe and critical ill COVID-19 patients","volume":"9","author":"Zhang","year":"2020","journal-title":"Emerg Microbes Infect"},{"key":"2025090700315083000_29.e1.e2.34","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1080\/23744235.2020.1802062","article-title":"Predominance of hospital-acquired bloodstream infection in patients with Covid-19 pneumonia","volume":"52","author":"Engsbro","year":"2020","journal-title":"Infect Dis"},{"key":"2025090700315083000_29.e1.e2.35","doi-asserted-by":"crossref","unstructured":"Giacobbe DR , Battaglini D , Ball L , et al . Bloodstream infections in critically ill patients with COVID\u201019. Eur J Clin Invest 2020;50.doi:10.1111\/eci.13319","DOI":"10.1111\/eci.13319"},{"key":"2025090700315083000_29.e1.e2.36","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1093\/cid\/ciaa524","article-title":"Coronavirus disease 2019, superinfections, and antimicrobial development: what can we expect?","volume":"71","author":"Clancy","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2025090700315083000_29.e1.e2.37","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-0691.2012.03964.x"},{"key":"2025090700315083000_29.e1.e2.38","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2015.01.003"},{"key":"2025090700315083000_29.e1.e2.39","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajic.2015.06.030"},{"key":"2025090700315083000_29.e1.e2.40","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0225765","article-title":"Serum procalcitonin as an independent diagnostic marker of bacteremia in febrile patients with hematologic malignancies","volume":"14","author":"Yang","year":"2019","journal-title":"PLoS One"},{"key":"2025090700315083000_29.e1.e2.41","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-139-2-200307150-00013"},{"key":"2025090700315083000_29.e1.e2.42","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2014.110288"},{"key":"2025090700315083000_29.e1.e2.43","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.39335.541782.AD"},{"key":"2025090700315083000_29.e1.e2.44","article-title":"Increased secondary infection in COVID-19 patients treated with steroids in New York City","author":"Obata","year":"2020","journal-title":"Jpn J Infect Dis"},{"key":"2025090700315083000_29.e1.e2.45","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.27000"},{"key":"2025090700315083000_29.e1.e2.46","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1007\/s00134-021-06346-w","article-title":"COVID-19 increased the risk of ICU-acquired bloodstream infections: a case-cohort study from the multicentric OUTCOMEREA network","volume":"47","author":"Buetti","year":"2021","journal-title":"Intensive Care Med"},{"key":"2025090700315083000_29.e1.e2.47","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.2147\/RMHP.S277963","article-title":"Analysis of the risk factors for nosocomial bacterial infection in patients with COVID-19 in a tertiary hospital","volume":"13","author":"Cheng","year":"2020","journal-title":"Risk Manag Healthc Policy"},{"key":"2025090700315083000_29.e1.e2.48","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0242533","article-title":"Low prevalence of bloodstream infection and high blood culture contamination rates in patients with COVID-19","volume":"15","author":"Yu","year":"2020","journal-title":"PLoS One"},{"key":"2025090700315083000_29.e1.e2.49","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.02015-19"},{"key":"2025090700315083000_29.e1.e2.50","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1016\/j.cmi.2020.07.016","article-title":"Bacterial co-infection and secondary infection in patients with COVID-19: a living rapid review and meta-analysis","volume":"26","author":"Langford","year":"2020","journal-title":"Clin Microbiol Infect"},{"key":"2025090700315083000_29.e1.e2.51","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.jinf.2020.05.046","article-title":"Co-infections in people with COVID-19: a systematic review and meta-analysis","volume":"81","author":"Lansbury","year":"2020","journal-title":"J Infect"}],"container-title":["European Journal of Hospital Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ejhpharm-2021-002776","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T07:32:01Z","timestamp":1757230321000},"score":1,"resource":{"primary":{"URL":"https:\/\/ejhp.bmj.com\/lookup\/doi\/10.1136\/ejhpharm-2021-002776"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,16]]},"references-count":51,"journal-issue":{"issue":"e1","published-online":{"date-parts":[[2022,3,6]]},"published-print":{"date-parts":[[2022,3]]}},"alternative-id":["10.1136\/ejhpharm-2021-002776"],"URL":"https:\/\/doi.org\/10.1136\/ejhpharm-2021-002776","relation":{},"ISSN":["2047-9956","2047-9964"],"issn-type":[{"type":"print","value":"2047-9956"},{"type":"electronic","value":"2047-9964"}],"subject":[],"published":{"date-parts":[[2021,8,16]]}}}